Replies to post #14643 on Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

LMAO...no one else is slamming Doc Williams work @ AP.

Whatever AP submitted to the FDA is what will be discussed. '

I posted info that would've told you the EOP2 Meeting isn't subjected to half ass/half baked trickling out data.

Meaning, they will discuss what has been submitted within the 4 corners of the documents within the time frame allotted for the meeting.

Any after the fact stuff is just that.

After the fact.

It's pass or fail.

So we can only hope the CEO got his story straight beforehand.

There isn't any do overs dude.

The FDA will be on to the next one.

Yuh-heard!

M$

Outro